Environment, Social, Governance
As a global pharmaceutical company, we stretch everyday to deliver safe and sustainable innovation and play our part in addressing some of the world’s most pressing challenges.
Discover Our Integrated Sustainability StrategyOur Latest Corporate Social Responsibility Updates
January 29, 2026
Fourth Quarter & Full Year 2025 Update
ESG Investor Roadshow
Sanofi was pleased to invite investors and analysts to participate in its ESG Investor Roadshow held in-person at the Sanofi Headquarters on Thursday, June 26, 2025.
Building on its foundation in corporate social responsibility, Sanofi provided a comprehensive deep-dive into its updated sustainability strategy, AIR, which focuses on the critical nexus between health and the environment.
Presenting our 2024 CSRD Report (ESG Report)
In Chapter 3 of the French Universal Registration Document (Declaration of Extra-financial Performance), we share our progress on our integrated sustainability strategy, prepared in alignment with the EU Corporate Sustainability Directive (CSRD) regime.
Environmental, Social and Governance Performance
ESG and commercial considerations are intrinsically linked and ongoing progress in our ESG performance is vital for Sanofi to succeed and grow in a sustainable way.
Leading the Way for Sustainable Finance
Sanofi is a pioneer of sustainable finance, with two Sustainability-linked Revolving Credit Facilities since 2020 and a Sustainability-Linked Bond, linked to its Global Health Unit, since 2021.
Product litigations
Information on Sodium Valproate (Depakine)
Information on Dengvaxia®
For Most Recent Esg Information, See Also Our:
Quarterly Results
ESG information throughout the quarterly results presentations and in the quarterly press releases
ESG Index
Our ESG Index serves as a centralized platform, consolidating all ESG-related disclosures.
ESG Key Performance Indicators (Excel)
See our key ESG Performance Indicators
Our US Prescription Medicine Pricing Principles
We work passionately to prevent, treat and cure illness and disease, understand and solve healthcare needs of people across the world, and transform the practice of medicine.
Quick Links
Corporate Governance
Reports and Publications
